Skip to Main Content

Paper Details

Antibody-drug conjugates targeting HER2-mutant or HER2-(non) amplified solid tumors: is HER2 an agnostic target?
Expert Opin Biol Ther
0
2023
Author NameAffiliation
Giuseppe CuriglianoEuropean Institute of Oncology, IRCCS
Giuseppe CuriglianoUniversity of Milan
  • 1 - 2

Datasets

Release 1.2